Hussman Strategic Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-105,000	Closed	-$788K	–	281
2024 Q2	$788K	Buy	105,000 +63,000	+150%	+$473K	0.22%	163
2024 Q1	$419K	Buy	+42,000	New	+$419K	0.1%	186